PSYCHOTROPIC DRUGS. Norman L. Keltner, RN, CRNP, EdD. David G. Folks, MD

Size: px
Start display at page:

Download "PSYCHOTROPIC DRUGS. Norman L. Keltner, RN, CRNP, EdD. David G. Folks, MD"

Transcription

1 PSYCHOTROPIC DRUGS Norman L. Keltner, RN, CRNP, EdD Associate Professor School of Nursing University of Alabama at Birmingham Birminghanij Alabama David G. Folks, MD Professor and Chair Creighton University Medical Center School of Medicine University of Nebraska Medical Center College of Medicine Department of Psychiatry Omaha, Nebraska Second Edition with 40 illustrations St. Louis Baltimore Boston Carlsbad Chicago Naples New York Philadelphia Portland London Madrid Mexico City Singapore Sydney Tokyo Toronto Wiesbaden

2 PART ONE CLINICAL PSYCHOPHARMACOLOGY, 1 UNIT 1 Introduction to Psychotropic Drug Use, 3 1 Psychiatric Care and Contemporary Treatment, 4 Benchmarks in Psychiatric Care: The Road From Confinement to Community, 5 Period of Enlightenment (Caring), 5 Period of Scientific Study (Curing), 6 Period of Psychotropic Drugs (Chemicals), 6 Period of Community Mental Health Care (Community), 8 Remarks, 8 2 Neurb anatomy, 10 Richard A. Sugerman F. Cleveland Kinney Central Nervous System, 10 Telencephalon (Cerebrum), 10 Diencephalon (Thalamic Nuclei), 10 Brain Stem, Cerebellum, Reticular Formation, and Spinal Cord, 14 Peripheral Nervous System, 18 Autonomic Nervous System, 18 Supraspinal Motor Pathways, 20 Basal Ganglia, 22 Limbic Lobe, 25 3 Neuropharmacology and Psychotropic Drugs, 28 Richard A. Sugerman Synaptic Transmission, 28 Types of Synapses, 30 Membrane Receptors, 30 Mechanisms of Receptor Action, 31 Neurotransmission, 31 Neuron Excitation and Inhibition, 31 Denning Neurotransmitters, 31 Action and Synthesis of Neurotransmitters, 31 Cholinergic System, 33 Monoamine Systems, 33 Neuropeptides, 35 Amino Acid Transmitters, 37 Neurotransmitters and Neurochemistry of Behavior, 39

3 xvi xvii \ UNIT II Drugs Used in the Treatment of Mental Disorders, 45 4 Schizophrenia and Other Psychoses, 46 Historical Considerations, 46 DSM-IV Terminology and Criteria, 47 Antipsychotic Drugs, 49 History, 52 Three Classification Systems: Molecular, Potency,Typicality, 52 Neurochemical Theory of Schizophrenia, 53 Pharmacologic Effects (Therapeutic Effects), 54 Psychiatric Symptoms Modified by Antipsychotic Drugs, 55 Other Uses and Effects, 56 Pharmacokinetics, 56 Side Effects, 59 Implications, 66 Chemical Class and Structure of Specific Drugs, 68 Atypical Antipsychotics or Serotonin/Dopamine Antagonists (SDAs), 71 Drugs in the Evaluation Phase, 76 Remarks, 76 5 Mood Disorders, 80 Historical Considerations, 80 Scope of the Problem, 80 Diagnostic Considerations, 81 Major Depression, 82 Bipolar Disorder, 83 Suicide and Other Risks, 83 Diagnostic Dilemmas, 83 Treatment Considerations, 84 Depression, 84 Bipolar Disorder, 84 Other Mood Disorders, 84 Antidepressants, 85 Historical Considerations, 85 Neurochemical Theory of Effectiveness, 86 Tricyclic, Heterocyclic, and Second-Generation Antidepressants, 90 Pharmacokinetics, 90 Side Effects, 91 Implications, 91 Specific Tricyclic Antidepressants, 95 Newer Antidepressant Agents, 96 Venlafaxine, 99 Bupropion, 102 Nefazodone, 102 Other New Antidepressants, 103 Monoamine Oxidase Inhibitors, 103 Pharmacokinetics, 106 Side Effects, 106 Specific Interactions, 107 Implications, 108 Specific Monoamine Oxidase Inhibitors, 110 Treatment Issues and Caveats, 111 Antimanic and Mood-Stabilizing Drugs, 113 Lithium, 113 Pharmacokinetics, 114 Side Effects, 115 Implications, 117 Alternative Antimanic and Mood-Stabilizing Drugs, 118 Valproic Acid, 118 Carbamazepine, 123 Benzodiazepines, 125 Miscellaneous Agents, Anxiety Disorders, Historical Considerations, 129 Diagnostic Considerations, 132 Anticipatory Anxiety, 132 Posttraumatic Stress Disorder, 132 Mixed Anxiety-Depression, 134 Generalized Anxiety, 134 Nonpsychiatric Anxiety, 135 Treatment, 135 Anxiolytics, 137 Benzodiazepines, 137 Pharmacologic Effect, 137 Pharmacokinetics, 140 Side Effects, 141 Implications, 141 Buspirone, 144 Pharmacokinetics, 144 Implications, 145 Specific Anxiety Disorders and Mixed Syndromes, 146 Panic Disorder, 146 Treatment, 147 Phobic Disorders, 149 Treatment, 149 Obsessive-Compulsive Disorder, 150 Treatment, 151 Seizure Disorders, 156 Epilepsy, 156 Categories of Seizures, 156 Antiepileptic Drugs, 160 Hydantoins: Prototype Drug, Phenytoin, 163 Pharmacologic Effects, 163 Pharmacokinetics, 164 Side Effects, 169 Implications, 170 Related Hydantoins, 173 Long-Acting Barbiturates: Prototype Drug, Phenobarbital, 173 Pharmacologic Effects, 173

4 xviii xix Pharmacokinetics, 173 Side Effects, 174 " Implications, 175 Related Barbiturates, 176 Succinimides: Prototype Drug, Ethosuximide, 177 Pharmacologic Effects, 177 Pharmacokinetics, 177 Side Effects, 177 Implications, 178 Related Succinimides, 178 ^ Oxazolidinediones: Prototype Drug, Trimethadione, 179 Pharmacologic Effects, 179 Pharmacokinetics, 179 Side Effects, 179 Implications, 179 Related Oxazolidinedione, 180 Benzodiazepines: Diazepam, Clonazepam, Clorazepate, 180 Diazepam Indication: Treating Status Epilepticus, 181 Clonazepam Indication: Lennox-Gastaut, 181 Clorazepate Indication: Partial Seizures, 182 Other Antiepileptics, 182 Carbamazepine, 182 Pharmacologic Effect, 182 Pharmacokinetics, 182 Side Effects, 183 Implications, 183 Valproic Acid and Derivatives, 184 Pharmacologic Effects, 184 Pharmacokinetics, 185 Side Effects, 185 Implications, 185 Related Drugs, 186 Gabapentin, 186 Lamotrigine, 187 Less Frequently Used Antiepileptics, 187 Acetazolamide, 187 Lidocaine, 187 Magnesium sulfate, 187 Paraldehyde, 187 Antiepileptics with Severe or Dangerous Side Effects, 188 Phenacemide, 188 Felbamate, 188 Agents Pending Approval by the FDA, Sleep Disorders, 190 Historical Considerations, 190 Diagnostic Considerations, 191 Drugs Used to Treat Insomnia, 194 Neurochemical Effects of Hypnotics, 197 Benzodiazepines, 198 Pharmacologic Effects, 198 Pharmacokinetics, 201 Side Effects, 206 Implications, 208 Specific Benzodiazepines, 209 Nonbenzodiazepine Hypnotic: Zolpidem, 210 Treatment Considerations, 211 Other Drugs Used to Treat Insomnia, 212 Discussion, 213 Other Sleep Disorders, 214 Hypersomnia, 214 Narcolepsy, 215 Sleep Apnea, 218 Parasomnias, 218 < Periodic Leg Movements (Restless Leg Syndrome), 218 Comorbid Conditions, Acute Psychoses and the Violent Patient, 223 Scope of the Problem, 223 The Clinical Approach, 223 Policies on Violence, 224 Diagnostic Considerations, 224 Assessment and Clinical Approach, 224 Drug Treatment, 227 Short-Term Treatment, 227 Long-Term Treatment, 233 Implications and Treatment Issues, Alcoholism and Other Substance Abuse Disorders, 240 Scope of the Problem, 240 Epidemiology, 240 Historical Perspective, 240 National Surveys, 241 Pregnancy Considerations, 242 Psychologic Considerations, 242 Genetic, Environmental, and Other Influences, 243 Genetic Influences, 243 Environmental Influences, 243 Psychiatric Influences, 244 Drug-Related Influences, 244 Neurobiologic Influences, 245 Diagnostic Considerations, 245 American Psychiatric Considerations, 246 Comorbidity, 246 Drug Treatment, 248 Short-Term Treatment Objectives, 248 Long-Term Treatment Objectives, 248 Drugs Used in the Treatment of Alcoholism, 249 Drugs Used to Treat Narcotic (Opioid) Dependence and Abuse, 251 Drugs Used to Treat Effects of Central Nervous System Stimulants, 253 Drugs Used to Treat Nicotine Dependence, 257

5 XX xxi Drugs Used to Treat Cannabis (Marijuana) Dependence, 260 Drugs Used to Treat Abuse of Phencyclidine and Similar Agents, 260 Drugs Used to Treat Sedative-Hypnotic and Anxiolytic Abuse and Dependence, 260 UNIT III Drug Issues Related to Psychopharmacology, Drugs Used for Electroconvulsive Therapy, 268 A Summative History ofect, 268 \ Historical Perspective on the Negative View, 269 Modern Electroconvulsive Therapy, 270 Indications, 270 Contraindications, 273 AdvantageSj 274 Disadvantages, 276 How Electroconvulsive Therapy Works, 276 Drugs Used in Electroconvulsive Therapy, 276 Succinylcholine, 277 Pharmacokinetics and Interactions, 277 Methohexital, 277 Pharmacokinetics, 278 Side Effects, 278 Interactions, 278 Atropine, 278 Pharmacokinetics, 278 Side Effects, 279 Interactions, Drugs of Abuse, 281 Leland N. Allen III Alcohol, 283 Etiologic Theories, 286 Pharmacokinetics, 287 Physiologic Effects, 289 Related Issues, 290 Other Central Nervous System Depressants, 292 Barbiturates, 292 Pharmacokinetics, 293 Physiologic Effects, 293 Related Issues, 293 Inhalants, 294 Narcotics (Opioids), 294 Pharmacokinetics, 295 Physiologic Effects, 295 Related Issues, 295 Specific Drugs, 296 Stimulants, 297 Cocaine, 297 Pharmacokinetics, 298 Physiologic Effects, 298 Amphetamines, 299 Pharmacokinetics, 299 Physiologic Effects, 299 Related Issues, 299 Hallucinogens, 300 Mescaline and Related Synthetic Substances, 301 Pharmacokinetics, 301 Physiologic Effects, 301 Psilocybin, Psilocin, 301 Pharmacokinetics, 301 Physiologic Effects, 301 Marijuana, 302 Pharmacokinetics, 302 / Physiologic Effects, 302 Lysergic Acid Diethylamide, 302 Pharmacokinetics, 302 Physiologic Effects, 303 Phencyclidine, 303 Pharmacokinetics, 303 Physiologic Effects, 303 Related Issues, 303 Remarks, Drugs Used to Stimulate the Central Nervous System, 308 Cerebral Stimulants, 308 Amphetamines, 308 Pharmacologic Effect, 309 Pharmacokinetics, 311 Side Effects, 311 Implications, 312 Other Prescription Central Nervous System Stimulants, 315 Methylphenidate, 315 Pharmacokinetics, 315 Side Effects, 316 Implications, 316 Pemoline, 316 Other Stimulants: Caffeine and Amphetamine-Like Anorectics, 317 Caffeine, 317 Phenylpropanolamine, 318 Treatment Considerations, 321 Treatment of Depression, 321 Treatment of Depressed Medically 111 Patients, 321 Use as a Challenge Test for Predicting a Response to Antidepressants, 322 Use in Elderly Persons, 322 Caffeine Augmentation of Electroconvulsive Therapy, 322 Treatment of Schizophrenia, 322 Miscellaneous Uses, 322 '

6 xxii 14 Drugs Used to Treat Extrapyramidal Side Effects, 325 Review of Parkinsonism, 325 Extrapyramidal Side Effects, 331 Drugs Used to Treat Parkinsonism, 332 Anticholinergic (Antiparkinson) Agents, 336 Pharmacologic Effects, 338 Side Effects, 338 Implications, 340 Patient Education, 341 Related Anticholinergic Drugs, 342 * Benztropine, 342 Biperiden, 342 Ethopropazine, 342 Procyclidine, 342 Diphenhydramine, 342 Issues in Anticholinergic Drug Administration, 343 Other Agents, 345 Benzodiazepines: Treatment of EPSEs, 345 Beta-Adrenergic Antagonists: Treatment of EPSEs, 345 Clonidine: Treatment of EPSEs, 345 Nifedipine and Verapamil: Treatment oftardive Dyskinesia, 345 Dantrolene: Treatment of Neuroleptic Malignant Syndrome, 345 UNIT IV Developmental Issues Related to Psychotropic Drugs, Psychopharmacology for Children, 350 Lawrence Scahill Scope of the Problem, 350 General Principles, 350 Psychotropic Medications Used with Children, 353 Stimulants, 353 Indications, 353 Empirical Support, 353 Mechanism of Action, 353 Clinical Management, 354 Side Effects of Central Nervous System Stimulants, 355 Toxic Effects, 355 Substance Abuse, 355 Antidepressants, 355 Indications, 355 Tricyclic Antidepressants, 356 Empirical Support, 356 Mechanism of Action, 357 Pharmacokinetics, 357 Clinical Management, 357 Side Effects, 358 Interactions, 358 Toxic Effects, 358 Selective Serotonin Reuptake Inhibitors, 358 Indications, 359 Obsessive-Compulsive Disorder, 359 Empirical Support, 359 i Mechanism of Action, 359 Pharmacokinetics, 360 Clinical Management, 360 Withdrawal of SSRIs and Duration of Therapy, 361 Augmentation Strategies, 361 SSRIs and Depression, 362 Other Antidepressant Medications, 362 Antipsychotic Drugs, 362 Indications, 362 Mechanism of Action, 364 Pharmacokinetics, 364 Clinical Management and Empirical Support, 364 Side Effects, 366 Toxic Effects, 367 Tardive Dyskinesia, 367 Lithium, 367 Indications, 367 Empirical Support, 367 Clinical Management, 368 Side Effects, 368 Alpha-2 Adrenergic Agents, 368 Indications, 368 Empirical Support, 368 Mechanism of Action, 368 Clinical Management, 369 Other Agents Used in the Treatment of Children with Psychiatric Disorders, Psychopharmacology for Adolescents, 374 Lawrence Scahill Scope of the Problem, 374 General Principles of Adolescent Psychopharmacology, 374 Strategies for Effective Administration, 374 Other Issues of Administration, 375 Psychotropic Medications Used with Adolescents, 376 Stimulants, 376 Indications, 376 Empirical Support, 376 Mechanism of Action, 377 Clinical Management, 377 Antidepressants, 378 Indications, 378 Empirical Support, 378 Mechanism of Action, 379 Clinical Management, 379 Antipsychotics, 380 Indications, 380 Empirical Support, 381 Mechanism of Action, 381 Clinical Management, 381 xxm

7 xxiv Lithium, 382 Indications, 382 Empirical Support, 384 Mechanism of Action, 384 Clinical Management, 384 Other Drugs Used in the Treatment of Bipolar Disorder, 385 Carbamazepine (Tegretol), 385 Valproate (Depakote), 386 Drugs Used in the Treatment of Aggressive Behavior, 386 Neuroleptics, 387 Lithium, 387 Anticonvulsants, 387 Alpha-2 Adrenergic Agents Tic Disorders, 387 Use of Combined Drug Therapies, Psychopharmacology for Elderly Persons, 391 Scope of the Problem, 391 General Factors Pertinent to Psychotropic Drug Therapy, 392 Pharmacokinetics, 394 Pharmacodynamics, 397 Drug Reactions, 398 Compliance, 399 Psychiatric Disturbances Prevalent in Late Life, 399 Mood Disorders, 399 Psychotic Disorders, 401 Anxiety Disorders and Acute Insomnia, 402 Mixed Anxiety-Depression, 404 ( Agitation and Aggression, 404 Delirium, "Sundowning," and Confusion Associated with Dementia, 405 Alzheimer's Disease and Related Disorders, 408 Management of Delirium, Dementia, and Alzheimer's Disease, 412 Supportive Care, 412 Drug Therapy Options, 413 Remarks, 416 PART TWO PSYCHOTROPIC DRUG PROFILES, 423 APPENDIX, 532 GENERAL INDEX, 535 DISORDERS INDEX, 562 DRUG INDEX, 567

Psychotropic Drugs 0, 4-

Psychotropic Drugs 0, 4- 0, 4- } -v Psychotropic Drugs NORMAN L. KELTNER, Ed D, RN Associate Professor, Graduate Program, University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama DAVID

More information

Manual of Clinical Psychopharmacology

Manual of Clinical Psychopharmacology Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School

More information

^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs

^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs ^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs wm, ROBERT M.JULIEN M.D.. PH.D. Claire D. Advokat, Ph.D. Louisiana State University and Joseph

More information

JULIO MOIZESZOWICZ: PSICOFARMACOLOGIA PSICODINAMICA. ASPECTOS NEUROQUIMICOS y PSICOLOGICOS

JULIO MOIZESZOWICZ: PSICOFARMACOLOGIA PSICODINAMICA. ASPECTOS NEUROQUIMICOS y PSICOLOGICOS 1 Books August 27, 2015 JULIO MOIZESZOWICZ: PSICOFARMACOLOGIA PSICODINAMICA. ASPECTOS NEUROQUIMICOS y PSICOLOGICOS (Psychodynamic Psychopharmacology. Neurochemical and Psychological Aspects) 4 th edition

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology

Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology Contemporary Psychiatric-Mental Health Nursing Chapter 7 The Science of Psychopharmacology Psychopharmacology A primary treatment mode of psychiatric-mental health nursing care Psychopharmacology - continued

More information

Psychobiology Handout

Psychobiology Handout Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are

More information

GOALS FOR THE PSCYHIATRY CLERKSHIP

GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.

More information

AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY, INC. PART I EXAMINATION IN PSYCHIATRY A AND B 2013 Content Outline

AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY, INC. PART I EXAMINATION IN PSYCHIATRY A AND B 2013 Content Outline 253 questions Percent Part A: Basic Concepts in Psychiatry I. Development through the life cycle 9% A. Infancy through adolescence 1. Personality development (e.g., moral development) 2. Developmental

More information

Clinical Geriatric Psychopharmacology

Clinical Geriatric Psychopharmacology Clinical Geriatric Psychopharmacology SECOND EDITION CARL SALZMAN, M.D. Director of Psychopharmacology Massachusetts Mental Health Center Associate Professor of Psychiatry Harvard Medical School Boston,

More information

The Maudsley Prescribing Guidelines in

The Maudsley Prescribing Guidelines in The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors

More information

DRUGS AND SOCIETY. Behavioral Medicines and Abusabie Drugs. Arthur P. Leccese, Ph.D. Kenyon College. PRENTICE HALL, Englewood Cliffs, New Jersey 07632

DRUGS AND SOCIETY. Behavioral Medicines and Abusabie Drugs. Arthur P. Leccese, Ph.D. Kenyon College. PRENTICE HALL, Englewood Cliffs, New Jersey 07632 DRUGS AND SOCIETY Behavioral Medicines and Abusabie Drugs Arthur P. Leccese, Ph.D. Kenyon College PRENTICE HALL, Englewood Cliffs, New Jersey 07632 CONTENTS PREFACE xv PART A PSYCHOPHARMACOLOGY CHAPTER

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

Test Bank for Essentials of Psychiatric Mental Health Nursing 1st Edition by Varcarolis

Test Bank for Essentials of Psychiatric Mental Health Nursing 1st Edition by Varcarolis Test Bank for Essentials of Psychiatric Mental Health Nursing 1st Edition by Varcarolis Link download full: https://testbankservice.com/download/test-bankforessentials-of-psychiatric-mental-health-nursing-1st-editionbyvarcarolis/

More information

Study Guide Unit 3 Psych 2022, Fall 2003

Study Guide Unit 3 Psych 2022, Fall 2003 Psychological Disorders: General Study Guide Unit 3 Psych 2022, Fall 2003 1. What are psychological disorders? 2. What was the main treatment for some psychological disorders prior to the 1950 s? 3. What

More information

Final Exam PSYC2022. Fall (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication with cannabis.

Final Exam PSYC2022. Fall (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication with cannabis. Final Exam PSYC2022 Fall 1998 (2 points) Give 2 reasons why it is important for psychological disorders to be accurately diagnosed. (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication

More information

OBJECTIVES PLAN OF LESSON

OBJECTIVES PLAN OF LESSON Unit: Behavioral Health Nursing Implementation:Keltner et al., Ch. 1, 2, 3, & Appendix; PowerPoint Presentation; Lesson: 1 Handouts; Lecture/Discussion; Transparencies Title: Historic Perspective of Mental

More information

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.

More information

GUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS

GUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS City and County of San Francisco Mayor Gavin Newsom Department of Public Health Community Behavioral Health Services 1380 Howard Street 5 th Floor San Francisco, CA 94103 GUIDELINES FOR THE USE OF PSYCHOACTIVE

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

An Overview on the Use of Psychotropic Medications

An Overview on the Use of Psychotropic Medications An Overview on the Use of Psychotropic Medications Marilyn B. Benoit, M.D. Chief Clinical Officer SVP, Clinical & Professional Affairs Classes of Medications Antidepressants Anti-anxiety Mood stabilizers

More information

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned

More information

Safe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA

Safe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA Psychotropic Drugs Safe and Effective Use of Psychotropic Drugs JMAJ 47(6): 259 264, 2004 Jun NAKAMURA Professor, Department of Psychiatry, School of Medicine, University of Occupational and Environmental

More information

Drugs, Society and Behavior

Drugs, Society and Behavior SOCI 270 Drugs, Society and Behavior Spring 2016 Professor Kurt Reymers, Ph.D. Chapter 8 Medication for Mental Disorders 1. Mental Disorders: a. The Medical Model Model: symptoms diagnosis determination

More information

Anticonvulsants Antiseizure

Anticonvulsants Antiseizure Anticonvulsants Antiseizure Seizure disorders Head trauma Stroke Drugs (overdose, withdrawal) Brain tumor Encephalitis/ Meningitis High fever Hypoglycemia Hypocalcemia Hypoxia genetic factors Epileptic

More information

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine

More information

Norpramin (desipramine)

Norpramin (desipramine) Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)

More information

Out with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications

Out with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications Program Outline Out with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications Rajiv Tandon, MD Professor of Psychiatry University of Florida College of Medicine

More information

A substance that reduces pain and may or may not have psychoactive properties.

A substance that reduces pain and may or may not have psychoactive properties. GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central

More information

Antidepressants and Sedatives. David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School

Antidepressants and Sedatives. David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School Antidepressants and Sedatives David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School Depression A frequent problem, affecting up to 5% of the population Common presentations

More information

TIAGABINE. THERAPEUTICS Brands Gabitril see index for additional brand names. Generic? Yes

TIAGABINE. THERAPEUTICS Brands Gabitril see index for additional brand names. Generic? Yes TIAGABINE THERAPEUTICS Brands Gabitril see index for additional brand names Generic? Yes Class Anticonvulsant; selective GABA reuptake inhibitor (SGRI) Commonly Prescribed for (bold for FDA approved) Partial

More information

The Nervous System. Chapter 4. Neuron 3/9/ Components of the Nervous System

The Nervous System. Chapter 4. Neuron 3/9/ Components of the Nervous System Chapter 4 The Nervous System 1. Components of the Nervous System a. Nerve cells (neurons) Analyze and transmit information Over 100 billion neurons in system Four defined regions Cell body Dendrites Axon

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed

More information

CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE

CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE PRESENTED AND APPROVED: DECEMBER 7, 2012 EFFECTIVE: FALL 2013-14 Prefix & Number CHD 110 Purpose of this submission: Change course title to reflect current

More information

Psychopathology: Biological Basis of Behavioral Disorders

Psychopathology: Biological Basis of Behavioral Disorders 1 6 Psychopathology: Biological Basis of Behavioral Disorders 16 Psychopathology: Biological Basis of Behavioral Disorders The Toll of Psychiatric Disorders Is Huge Schizophrenia is the major neurobiological

More information

Faculty of dentistry Second year CND Course CNS Drugs Dr. Ali Awadallah

Faculty of dentistry Second year CND Course CNS Drugs Dr. Ali Awadallah Faculty of dentistry Second year CND Course CNS Drugs Dr. Ali Awadallah 0912320825 Drugs that act upon the central nervous system (CNS) influence the lives of everyone, everyday. Drugs that affect the

More information

DONT GIVE MEDICINE IF THE PATIENT DOES NOT NEED MEDICINE.

DONT GIVE MEDICINE IF THE PATIENT DOES NOT NEED MEDICINE. **Know about skin issues/rash, hypotension, vascular issues, systemic problems. No nausea, vomiting, headache. **The route it is USUALLY given.. **Know what the drug is used FOR, and the biggest SIDE EFFECT.

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

Mentoring Session: Participant Cases

Mentoring Session: Participant Cases Handout for the Neuroscience Education Institute (NEI) online activity: Mentoring Session: Participant Cases The Case: 55-year-old patient with depression and anxiety The Question: What to do when antidepressants

More information

PHARMACOLOGY Vol. I - Neuropsychopharmacology - Mirjam A.F.M. Gerrits and Jan M. van Ree

PHARMACOLOGY Vol. I - Neuropsychopharmacology - Mirjam A.F.M. Gerrits and Jan M. van Ree NEUROPSYCHOPHARMACOLOGY Mirjam A.F.M. Gerrits and Jan M. van Ree Rudolf Magnus Institute of Neuroscience, Department of Neuroscience and Pharmacology, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.

More information

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif Anxiolytic & Hypnotic Drugs Asst Prof Dr Inam S Arif isamalhaj@yahoo.com Anxiolytic & Hpnotic Agents Anxiety: unpleasant state of tension, apprehension or uneasiness, characterised by, tachycardia, sweating,

More information

The Virtual En-psych-lopedia by Dr. Bob. DSM-IV Diagnoses and Codes, Alphabetical Listing

The Virtual En-psych-lopedia by Dr. Bob. DSM-IV Diagnoses and Codes, Alphabetical Listing The Virtual En-psych-lopedia by Dr. Bob DSM-IV Diagnoses and Codes, Alphabetical Listing DSM-5 listings: alphabetical, by diagnosis numerical, by ICD-9-CM and ICD-10-CM code This is just an alphabetical

More information

Controlled Substance Monitoring and Drugs of Abuse Testing Determination

Controlled Substance Monitoring and Drugs of Abuse Testing Determination CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,

More information

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Accidents, risk of, with insufficient sleep, 318 Acquired immunodeficiency syndrome (AIDS), comorbid with narcolepsy, 298 299 Actigraphy, in

More information

Chapter 03: Psychobiology and Psychopharmacology Halter: Varcarolis Foundations of Psychiatric Mental Health Nursing: A Clinical Approach, 8th Edition

Chapter 03: Psychobiology and Psychopharmacology Halter: Varcarolis Foundations of Psychiatric Mental Health Nursing: A Clinical Approach, 8th Edition Chapter 03: Psychobiology and Psychopharmacology Halter: Varcarolis Foundations of Psychiatric Mental Health Nursing: A Clinical Approach, 8th Edition MULTIPLE CHOICE 1. A patient asks, What are neurotransmitters?

More information

Anxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when

Anxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when Anxiety s J. H. Atkinson, M.D. HIV Neurobehavioral Research Center University of California, San Diego Department of Psychiatry & Veterans Affairs Healthcare System, San Diego Materials courtesy of Dr.

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

Clinical Guideline for the Management of Bipolar Disorder in Adults

Clinical Guideline for the Management of Bipolar Disorder in Adults Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:

More information

Asperger s Syndrome. severe difficulties interacting socially (Gillberg 2002). He named this difficulty

Asperger s Syndrome. severe difficulties interacting socially (Gillberg 2002). He named this difficulty Julie Burton 7.16.2012 ED 243 Paper Asperger s Syndrome History In 1944 an Austrian pediatrician named Hans Asperger wrote an article about a group of school- aged boys when he discovered that some of

More information

OBJECTIVES. 1. Become familiar with common classes of psychotropic medications, indications for their use, and side effects.

OBJECTIVES. 1. Become familiar with common classes of psychotropic medications, indications for their use, and side effects. OBJECTIVES 1. Become familiar with common classes of psychotropic medications, indications for their use, and side effects. 2. Use familiar conditions, as drawn from current caseloads, to evaluate the

More information

Part ONE Answer ALL questions. Write the correct answer CLEARLY in the answer grid provided.

Part ONE Answer ALL questions. Write the correct answer CLEARLY in the answer grid provided. UNIVERSITY OF EAST ANGLIA School of Pharmacy Main Series UG Examination 2012-2013 CLINICAL THERAPEUTICS 7: PSYCHIATRY PHA-MHBY Time allowed: 2 hours Part ONE Answer ALL questions. Write the correct answer

More information

TOP APS DRUGS - DIVALPROEX SODIUM BRAND NAME: DEPAKOTE (ER)

TOP APS DRUGS - DIVALPROEX SODIUM BRAND NAME: DEPAKOTE (ER) divalproex sodium TOP APS DRUGS - DIVALPROEX SODIUM BRAND NAME: DEPAKOTE (ER) Pharmacodynamics study of what a drug does to the body Divalproex sodium is chemically compounded from sodium valproate and

More information

Buspirone Carbamazepine Diazepam Disulfiram Ethosuximide Flumazeil Gabapentin Lamotrigine

Buspirone Carbamazepine Diazepam Disulfiram Ethosuximide Flumazeil Gabapentin Lamotrigine CNS Depressants Buspirone Carbamazepine Diazepam Disulfiram Ethosuximide Flumazeil Gabapentin Lamotrigine Lorazepam Phenobarbital Phenytoin Topiramate Valproate Zolpidem Busprione Antianxiety 5-HT1A partial

More information

Risperidone as a Janus in Mood Disorder

Risperidone as a Janus in Mood Disorder KISEP Review Clinical Psychopharmacology and Neuroscience 2003; 1: 7-21 Risperidone as a Janus in Mood Disorder Doh Joon Yoon - Key points KEY WORDS: INTRODUCTION Address for correspondence: - - - - Risperidone

More information

NATIONAL ACADEMY OF NEUROPSYCHOLOGY

NATIONAL ACADEMY OF NEUROPSYCHOLOGY NATIONAL ACADEMY OF NEUROPSYCHOLOGY CLINICAL PSYCHOPHARMACOLOGY SYLLABUS OVERVIEW The goal of this CE is to provide participants with our current understanding of the molecular sites and mechanisms of

More information

FLASH CARDS. Kalat s Book Chapter 15 Alphabetical

FLASH CARDS.   Kalat s Book Chapter 15 Alphabetical FLASH CARDS www.biologicalpsych.com Kalat s Book Chapter 15 Alphabetical antipsychotic drugs antipsychotic drugs Neuroleptic drugs. Used to treat schizophrenia. Primarily block dopamine receptors. atypical

More information

MODEL PSYCHOPHARMACOLOGY CURRICULUM

MODEL PSYCHOPHARMACOLOGY CURRICULUM Third Edition MODEL PSYCHOPHARMACOLOGY CURRICULUM For Psychiatric Residency Programs, Training Directors and Teachers of Psychopharmacology VOLUME I By A Committee of the American Society of Clinical Psychopharmacology

More information

MAINTENANCE OF CERTIFICATION EXAMINATION IN PSYCHIATRY

MAINTENANCE OF CERTIFICATION EXAMINATION IN PSYCHIATRY MAINTENANCE OF CERTIFICATION EXAMINATION IN PSYCHIATRY The American Board of Psychiatry and Neurology, Inc. (ABPN) has issued new, twodimensional content specifications for the psychiatry, neurology and

More information

DRUGS THAT ACT IN THE CNS

DRUGS THAT ACT IN THE CNS DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment

More information

MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES

MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES Urine drug testing (UDT) provides objective information to assist clinicians in identifying the presence or absence of drugs or drug

More information

distinguish between structural isomers (but not necessarily stereoisomers), including, but not

distinguish between structural isomers (but not necessarily stereoisomers), including, but not CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,

More information

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS Formulary and Prescribing Guidelines 9.1 Introduction Movement disorders and extrapyramidal side effects can manifest in the

More information

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant. 1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number

More information

Elavil (amitriptyline)

Elavil (amitriptyline) Generic name: Amitriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets; 10 mg/ml injection Available in generic: Yes Drug class: Tricyclic antidepressant General Information

More information

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines

More information

Pamelor (nortriptyline)

Pamelor (nortriptyline) Generic name: Nortriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg capsules; 10 mg/5 ml oral solution Available in generic: Yes Drug class: Tricyclic antidepressant General Information Pamelor

More information

A. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions.

A. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions. Pharmacology - Problem Drill 17: Central Nervous System Depressants Question No. 1 of 10 Instructions: (1) Read the problem statement and answer choices carefully (2) Work the problems on paper as 1. occur(s)

More information

Benzodiazepines. Benzodiazepines

Benzodiazepines. Benzodiazepines : History 1950s - Invented by Swiss chemists who identified its sedative effects 1950s 60s - Chlordiazepoxide (Librium) marketed as a safer alternative to barbiturates; along with newer benzodiazepines

More information

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology,

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology, Pharmacology An Introduction Henry Hitner, Ph.D. Department Neuroscience, Physiology, Philadelphia College of Osteopathie Medicine Philadelphia, Pennsylvania Adjunct Professor, Pharmacology Physician Assistant

More information

ES.S10: Drugs and the Brain Syllabus Spring 2013 Zak Fallows

ES.S10: Drugs and the Brain Syllabus Spring 2013 Zak Fallows ES.S10: Drugs and the Brain Syllabus Spring 2013 Zak Fallows About the Class: One-Sentence Description: This class is a multidisciplinary introduction to pharmacology, neurotransmitters, drug mechanisms,

More information

Classes of Neurotransmitters. Neurotransmitters

Classes of Neurotransmitters. Neurotransmitters 1 Drugs Outline 2 Neurotransmitters Agonists and Antagonists Cocaine & other dopamine agonists Alcohol & its effects / Marijuana & its effects Synthetic & Designer Drugs: Ecstasy 1 Classes of Neurotransmitters

More information

CERTIFICATION EXAMINATION IN PSYCHIATRY 2016 Content Blueprint (October 27, 2015) Part A Basic Concepts in Psychiatry

CERTIFICATION EXAMINATION IN PSYCHIATRY 2016 Content Blueprint (October 27, 2015) Part A Basic Concepts in Psychiatry CERTIFICATION EXAMINATION IN PSYCHIATRY 2016 Content Blueprint (October 27, 2015) Number of questions: 120 Part A Basic Concepts in Psychiatry 01. Development through the life cycle 1-3% 02. Behavioral

More information

Drugs, the Brain, and Behavior SECOND EDITION. Chapter 17, Environmental Neurotoxicants and Endocrine Disruptors

Drugs, the Brain, and Behavior SECOND EDITION. Chapter 17, Environmental Neurotoxicants and Endocrine Disruptors Psychopharmacology Drugs, the Brain, and Behavior SECOND EDITION Jerrold S. Meyer University of Massachusetts Linda F. Quenzer University of Hartford Chapter 17, Environmental Neurotoxicants and Endocrine

More information

Tianeptine Dependence: A Case Report

Tianeptine Dependence: A Case Report CASE REPORT Tianeptine Dependence: A Case Report Syed Nabil, Ng Chong Guan, Rusdi Abd Rashid Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Abstract

More information

Anti-Depressant Medications

Anti-Depressant Medications Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change

More information

DSM-5 UPDATE. Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION

DSM-5 UPDATE. Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION DSM-5 UPDATE Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION October 2017 DSM-5 Update October 2017 Supplement to Diagnostic and Statistical Manual of Mental Disorders,

More information

AACN PCCN Review. Behavioral

AACN PCCN Review. Behavioral AACN PCCN Review Behavioral Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com 0 Behavioral I. INTRODUCTION PCCN

More information

DISEASES AND DISORDERS

DISEASES AND DISORDERS DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abuse alcohol, aggression and, 52 53 substance, aggression and, 52 54 ACE. See Aid to Capacity Evaluation (ACE). AEDs. See Antiepileptic

More information

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the normal processing of fear vs fear processing

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,

More information

Νευροφυσιολογία και Αισθήσεις

Νευροφυσιολογία και Αισθήσεις Biomedical Imaging & Applied Optics University of Cyprus Νευροφυσιολογία και Αισθήσεις Διάλεξη 19 Ψυχασθένειες (Mental Illness) Introduction Neurology Branch of medicine concerned with the diagnosis and

More information

Washtenaw Community College Comprehensive Report. PSY 296 Neuropsychology of Addiction Effective Term: Winter 2019

Washtenaw Community College Comprehensive Report. PSY 296 Neuropsychology of Addiction Effective Term: Winter 2019 Washtenaw Community College Comprehensive Report PSY 296 Neuropsychology of Addiction Effective Term: Winter 2019 Course Cover Division: Humanities, Social and Behavioral Sciences Department: Behavioral

More information

Tofranil and Tofranil-PM (imipramine)

Tofranil and Tofranil-PM (imipramine) Tofranil and Tofranil-PM (imipramine) Generic name: Imipramine Available strengths: 10 mg, 25 mg, 50 mg tablets; 75 mg, 100 mg, 125 mg, 150 mg capsules (Tofranil-PM) Available in generic: Yes Drug class:

More information

SYLLABUS FOR THE PSYCHIATRY CLERKSHIP **FOR PA STUDENTS**

SYLLABUS FOR THE PSYCHIATRY CLERKSHIP **FOR PA STUDENTS** SYLLABUS FOR THE PSYCHIATRY CLERKSHIP **FOR PA STUDENTS** I. LEARNING OBJECTIVES (9/28/2015) At the completion of the Psychiatry Clerkship, students should be able to demonstrate mastery of the following

More information

The Nervous System Mark Stanford, Ph.D.

The Nervous System Mark Stanford, Ph.D. The Nervous System Functional Neuroanatomy and How Neurons Communicate Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Addiction Medicine and Therapy Services The Nervous System In response

More information